Tamsulosin and Intraureteral Aminophylline for Ureteral Access During RIRS

Condition(s) studied

Investigational drug(s) / intervention(s)

Tamsulosin: Tamsulosin 0.4 mg capsule once daily for 7 days before retrograde intrarenal surgery.

Placebo Capsule: Matching placebo capsule for tamsulosin, taken once daily for 7 days before retrograde intrarenal surgery.

Intraureteral Aminophylline: Aminophylline 250 mg/10 mL will be diluted with 10 mL normal saline 0.9% to a total volume of 20 mL. The solution will be instilled intraureterally through an open-end ureteric catheter positioned in the distal ureter on the study side. After a standardized 5-minute waiting period, one controlled attempt will be made to place the planned 10/12 Fr ureteral access sheath.

Intraureteral Placebo: Normal saline 0.9% to a total volume of 20 mL will be instilled intraureterally through an open-end ureteric catheter positioned in the distal ureter on the study side. After a standardized 5-minute waiting period, one controlled attempt will be made to place the planned 10/12 Fr ureteral access sheath.

Study summary

This multicenter randomized controlled trial will evaluate whether preoperative tamsulosin, intraureteral aminophylline, or their combination can improve ureteral access during primary retrograde intrarenal surgery for renal stones. Adult patients with unilateral renal stones measuring 2 cm or less and planned placement of a 10/12 Fr ureteral access sheath will be randomly assigned to one of four groups in a 2x2 factorial design. Participants will receive either tamsulosin or placebo for 7 days before surgery and either intraureteral aminophylline or intraureteral placebo during the procedure. The main outcome will be successful first-attempt placement of the planned 10/12 Fr ureteral access sheath after study solution instillation, without active ureteral dilatation, sheath downsizing, prestenting with deferred surgery, or abandonment of the procedure due to access failure.

Eligibility

Primary outcome measure(s)

• Successful First-Attempt 10/12 Fr Ureteral Access Sheath Placement — During the index retrograde intrarenal surgery procedure
  Successful placement of the planned 10/12 Fr ureteral access sheath at the first standardized post-instillation attempt during primary retrograde intrarenal surgery, without active ureteral dilatation, sheath downsizing, prestenting with deferred retrograde intrarenal surgery, or abandonment of the procedure due to access failure.

Trial sites (3)

On this site

More Beni-Suef University trials in Egypt

Other trials for the same condition